Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  glutamine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Glutamine to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/97)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-959251, NCI-P95-0069
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065974, NCCTG-969256, NCI-P97-0127, NCT00003170
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 06.23.CLI, NCT00455247
Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OXALI_L_03768, U1111-1116-9494, NCT01087658
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 1 to 21
Sponsor: Other
Protocol IDs: CDR0000067069, RPCI-RP-9810, NCI-G99-1521, NCT00003898
Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GI-05-0024, NCT00255229
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 5 to 21
Sponsor: Other
Protocol IDs: AAAA6806, CPMC-ICCR-3349, CPMC-AAAA6806, NCT00365768
Start Over